Atlas Trials

Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH

Clinical trial NCT06350032 · RECRUITING

Trial details

NCT number
NCT06350032
Sponsor
AOP Orphan Pharmaceuticals AG
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Pulmonary Arterial Hypertension
Start date
2024-07-31
Primary completion
2028-11-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.